APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.
about
Purinergic signalling and cancerDeadly allies: the fatal interplay between platelets and metastasizing cancer cellsCD47 regulates bone mass and tumor metastasis to bonemiR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit.Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells.Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy.Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapyThe ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs.Cancer to bone: a fatal attraction.Purinergic signalling in the musculoskeletal system.P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic windowA randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancerActivated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding.The platelet contribution to cancer progression.New therapeutic targets for cancer bone metastasisInhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis.Platelet-targeted pharmacologic treatments as anti-cancer therapy.Lunasin-aspirin combination against NIH/3T3 cells transformation induced by chemical carcinogens.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?The role of platelets and megakaryocytes in bone metastasis.Purinergic Signalling: Therapeutic Developments.The bone microenvironment - Multiple players involved in cancer progression.Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.
P2860
Q24618782-A802F266-8F24-4109-AB0E-B3C4E8640B0FQ24623647-324F0AA9-F04F-4CDF-8D6A-7C8D46679346Q24651925-ED3F3548-0945-4EE3-8496-91139CA9893BQ30407836-5FF26E11-B721-496E-9205-0FB2D36F2A01Q33752896-51250FE9-3E78-47E6-85AA-AC54FC9CE7E6Q34056033-7F3EBF80-D808-403A-9C2E-8376C01FE082Q34777793-F710BA34-8A7C-4E03-8A9B-D7B89AA30709Q36267681-447686D2-92E6-4D85-810E-02ADA8E50BC9Q36290218-3AB12531-2E84-47EF-9BCA-BC7B520A6856Q36611493-A13ABCA9-94A3-4C75-AF1E-837DD97AD18EQ36884628-87E76682-A6A0-4589-9880-C3129D74EFCEQ37468714-2802CB59-CFEA-4480-8B98-303DEAED5AB9Q37494937-0E41D5C4-2F46-4AA2-8AF3-0C8C99BD3D36Q37630295-DBCB9292-8B64-4BAE-9AED-B376534F25BBQ37645070-8A92E871-2E4E-4357-8936-ADC68255BAB2Q37805788-EF0D5A5F-0C5A-4D43-8DAA-03BC50DB1C8AQ38473066-159C2762-1679-4247-B535-7FC0DCF48098Q38553003-AD06AAA2-C3A9-47FA-8283-F3137F8AEB29Q38657846-5E88024F-F6C1-4922-B940-7B15C425180FQ39544493-4C8F36BC-7802-4032-98B0-6CBE0E67FDDCQ41420993-8F559F1A-2886-4CB4-B994-B74B1204662BQ41454830-8CF16091-5D3E-4C1D-9E96-DAECB78F513AQ42367885-23760D1E-DB82-4BE8-9060-088614A17BB1Q42383426-75F4B851-E7D0-40BE-B3CB-18A538E787C1Q43102079-E7224604-5EE2-463A-9248-AD33C9925732Q47400340-93BDC455-EA6F-4CA9-9C01-6BF6EB649F75
P2860
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.
@en
type
label
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.
@en
prefLabel
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.
@en
P2093
P2860
P356
P1476
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice
@en
P2093
Angela C Hirbe
David Piwnica-Worms
Desiree H Floyd
Julie L Prior
Katherine Weilbaecher
Mark C Eagleton
Matthew Kramer
Nikki Dowland
Ridong Chen
Soon Seog Jeong
P2860
P304
P356
10.1002/JCB.21709
P577
2008-07-01T00:00:00Z